Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) StudyBrian Kwan, Raymond R. Townsend, Tobias Fuhrer et al.|American Journal of Kidney Diseases|2020Cited by 86
Glycolytic lactate in diabetic kidney diseaseManjula Darshi, Luxcia Kugathasan, Soumya Maity et al.|JCI Insight|2024Cited by 50
High-Throughput Metabolomics and Diabetic Kidney Disease Progression: Evidence from the Chronic Renal Insufficiency (CRIC) StudyJing Zhang, Loki Natarajan, Tobias Fuhrer et al.|American Journal of Nephrology|2022Cited by 42
Urinary Proteomics Identifies Cathepsin D as a Biomarker of Rapid eGFR Decline in Type 1 DiabetesChristine P. Limonte, Insa M. Schmidt, Tomáš Vaisar et al.|Diabetes Care|2022Cited by 37
Changes in plasma and urine metabolites associated with empagliflozin in patients with type 1 diabetesHongyan Liu, David Z.I. Cherney, Vikas S. Sridhar et al.|Diabetes Obesity and Metabolism|2021Cited by 32